Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Epilepsy × Anticonvulsants × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Tuberous Sclerosis Complex-associated Refractory Seizures 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Epilepsy 1 Drug Resistant Epilepsy 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Everolimus 2 perampanel 1 clevidipine 1 Sirolimus 1 Sevoflurane 1 Propofol 1 Nitrous Oxide 1 Lidocaine 1 Immunoglobulins, Intravenous 1 Glycopyrrolate 1 Dexmedetomidine 1 Anticonvulsants 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04650204 2023-06-22

Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy

Mayo Clinic

Phase 4 Terminated

4 enrolled 9 charts

Drug Resistant Epilepsy, Epilepsy, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡